Investment Insights
Schwab is viewed as a solid investment despite recent market fears, with its reputation unjustly affected by the banking crisis. Meanwhile, Moderna faces a downturn attributed to the fading COVID boom, but its potential in mRNA technology could signal future growth opportunities for those with a long-term perspective.In this clip
From this podcast
The Prof G Pod with Scott Galloway
Prof G Markets: NVIDIA’s Valuation and AI’s Negative Sum Game — with Aswath Damodaran
Related Questions